GlassScriptPhysician profile
Colleen Manzo
NPI 1255857181
$400.34
in general payments reported to CMS, 2019-2025
9 companies · $34.70 in 2025
The $34.70 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.66 · 2024: $340 · 2025: $34.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kedrion Biopharma, INC. | $98.49 | 2024 | Albuked, Rhogam Ultra-Filtered Plus, Koate |
| Jazz Pharmaceuticals INC. | $82.57 | 2024 | |
| Chiesi USA, INC. | $71.61 | 2024-2025 | Elfabrio |
| Octapharma USA, INC. | $33.39 | 2024 | Wilate - Von Willebrand Factor/Coagulation Factor Viii Complex (Human) |
| Y-Mabs Therapeutics, INC. | $30.88 | 2024 | Danyelza |
| Abiomed | $25.66 | 2021 | |
| Genzyme Corporation | $23.33 | 2024 | |
| Rare Disease Therapeutics, INC. | $19.18 | 2024 | Purixan |
| Hema Biologics, LLC | $15.23 | 2024 | Sevenfact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Manzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.